NCT06585410 2026-02-25
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Recruiting
Regeneron Pharmaceuticals
Mayo Clinic
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
University of Michigan Rogel Cancer Center